Search clinical trials for: Ciclesonide

Total 85 results

AstraZeneca

Completed

To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)

Rhinitis, Allergic, Seasonal | Hay Fever

United States
Boehringer Ingelheim

Completed

Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD

Pulmonary Disease, Chronic Obstructive

Belgium, Denmark, Germany, Netherlands
Hvidovre University Hospital

Recruiting

Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma

Asthma

Denmark
AstraZeneca

Completed

Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137)

Asthma

Malaysia, Taiwan
AstraZeneca

Completed

Efficacy of Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used for Treatment of Mild Asthma in Children (4 to 11 Years) (BY9010/CA-101) (POPCICLE)

Asthma

Canada, Hungary, South Africa
AstraZeneca

Completed

Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142)

Asthma

Germany, South Africa, Austria, Canada, Poland
AstraZeneca

Completed

Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)

Asthma

India
University of Nottingham
Nottingham University Hospitals NHS Trust; University Hospitals, Leicester

Completed

Small Particle Steroids in Refractory Asthma (SPIRA)

Asthma

United Kingdom
AstraZeneca

Completed

Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102)

Asthma

Canada
AstraZeneca

Completed

Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)

Asthma

France, Germany, Hungary, South Africa
AstraZeneca

Completed

Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)

Asthma

United Kingdom
AstraZeneca

Completed

Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136)

Asthma

Korea, Republic of
AstraZeneca

Completed

Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129)

Asthma

Belgium
AstraZeneca

Completed

Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)

Asthma

South Africa, Germany, Brazil, Hungary, Poland, Portugal
AstraZeneca

Completed

Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)

Asthma

United Kingdom, Switzerland, Belgium, France, Italy, Spain, Netherlands
AstraZeneca

Completed

Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208)

Asthma

Denmark
AstraZeneca

Completed

Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)

Allergic Rhinitis | Perennial Allergic Rhinitis | Hay Fever

United States
AstraZeneca

Completed

Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)

Asthma

Hungary, South Africa, Poland, Spain, Canada, Australia, Czech Republic
AstraZeneca

Completed

Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408)

Rhinitis, Allergic, Perennial

United States
Ophthalmic Consultants of Connecticut

Unknown

Patient Satisfaction and Tear Osmolarity With the Use of Blink Tears, Blink Gel Tears and Systane Balance

Dry Eye

United States
Grünenthal Colombiana S.A.

Completed

Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric Asthma

Asthma

Colombia
Texas Tech University Health Sciences Center, El...

Withdrawn

Regulating Urine pH Levels to Alleviate Chronic Joint Pain

Arthritis

United States
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Butylated Hydroxytoluene and BI 54903 XX Via Respimat® Soft MistTM Inhaler B in Healthy Male Volunteers

Healthy
AstraZeneca

Completed

Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)

Asthma

Netherlands
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma (VIDA)

Asthma

United States
Tehran University of Medical Sciences

Unknown

Ciclesonide vs Fluticasone Nasal Sprays in Nasal Poplyposis

Chronic Rhinosinustis With Polyps
Cambridge University Hospitals NHS Foundation Trust
GlaxoSmithKline; National Institute for Health Research, United Kingdom; Kidney... and other collaborators

Recruiting

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V (PROTECT-V)

Covid19

United Kingdom
National Taiwan University Hospital
Academia Sinica, Taiwan

Recruiting

Evaluate the Therapeutic Effect of Inhaled Corticosteroid in Asthmatic Children

Asthma

Taiwan
Infante, Javier Molina, M.D.

Unknown

Efficacy and Safety of Split-dose Citrafleet Administered From 2 to 6 Hours Before Morning Colonoscopies

Colonoscopy | Bowel Cleansing

Spain
ANRS, Emerging Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Recruiting

Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection (COVERAGE-A)

Covid19 | SARS-CoV2 Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Covid19 Drug Treatment

Burkina Faso, Guinea
University Hospital, Bordeaux
University of Bordeaux

Completed

Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation (COVERAGEFrance)

Corona Virus Infection | Sars-CoV2

France
AstraZeneca
Nycomed GmbH

Completed

A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma (RAINBOW)

Asthma

Hungary, South Africa, Russian Federation, Spain, Poland, Germany, Bulgaria, Romania, Ukraine
USDA Beltsville Human Nutrition Research Center

Completed

Novel Metabolites of Beta-Carotene and Lycopene

Healthy

United States
Mansoura University

Completed

Analgesia of Erector Spinae Plane Block Versus Quadratus Lumborum Block

Colorectal Cancer

Egypt
Societe Internationale d'Oncologie Pediatrique

Completed

Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma

Sarcoma | Childhood Malignant Fibrous Histiocytoma of Bone

United Kingdom

3

Subscribe